Methylphenidate Hydrochloride Extended-release Capsules (la)
Marketed by: Actavis (Morristown, NJ)
Compared to: Ritalin (Novartis)
Indication: The FDA approved methylphenidate hydrochloride extended-release capsules (LA), a central nervous system stimulant, for the treatment of attention-deficit/hyperactivity disorder. Actavis has first-to-file exclusivity on the 20-, 30-, and 40-mg strengths. Methylphenidate hydrochloride extended-release capsules (LA) are administered orally once daily in the morning. Alternately, the capsule contents may be sprinkled on a small amount of applesauce and immediately consumed. Methylphenidate hydrochloride extended-release capsules (LA) should not be administered to children younger than 6 years, as safety and efficacy in this age group has not been established.
Dosage Form: Capsules: 20, 30, and 40 mg
For More Information: www.actavis.us
Marketed by: Sancilio & Company, Inc (Riviera Beach, FL)
Indication: Sancilio & Company, Inc announced the release of PréNata, a generic prenatal multivitamin indicated to provide vitamin and mineral supplementation throughout pregnancy and during the postnatal period for both lactating and nonlactating mothers. The fruit-flavored tablets are also useful for improving nutritional status prior to conception. The recommended dosage is 1 tablet daily with a meal. The chewable formulation provides an alternative to patients who experience nausea from large or difficult-to-swallow tablets. Patients can also crush PréNata tablets to take with food or swallow with water without affecting their nutritional value.
Dosage Form: Chewable tablets in 90-count bottles
For More Information: www.sancilio.com
Clobetasol Propionate Shampoo, 0.05%
Marketed by: Sandoz (Princeton, NJ)
Compared to: Clobex Shampoo, 0.05% (Galderma Laboratories)
Indication: Sandoz announced the availability of their authorized generic clobetasol propionate shampoo, 0.05%, in the United States. Clobetasol propionate shampoo, 0.05%, is a topical corticosteroid indicated for the treatment of moderate to severe forms of scalp psoriasis in patients 18 years and older. Treatment with clobetasol propionate shampoo, 0.05%, should be limited to 4 weeks because of its potential to suppress the hypothalamic-pituitary-adrenal axis. The total dosage should not exceed 50 g (50 mL or 1.75 fl oz) per week.
Dosage Form: Shampoo: supplied in 4–fl oz bottles
For More Information: www.us.sandoz.com
Lamivudine and Zidovudine Tablets USP
Marketed by: Teva Pharmaceuticals (North Wales, PA)
Compared to: Combivir Tablets (ViiV Healthcare)
Indication: Teva Pharmaceuticals announced the introduction and availability of lamivudine and zidovudine tablets USP, which are AB rated and bioequivalent to Combivir Tablets. Lamivudine and zidovudine tablets are a combination of 2 nucleoside analogue reverse transcriptase inhibitors indicated for the treatment of HIV-1 infection. The dosage for adults and adolescents weighing 30 kg or more is 1 tablet twice daily. Pediatric dosing should be based on body weight and should not exceed adult dosing. This fixed-dose product should not be used in pediatric patients weighing less than 30 kg, or in patients requiring dose adjustment.
Dosage Form: Tablets: 150/300 mg lamivudine/zidovudine
For More Information: www.tevausa.com
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs